2024 Q2 Form 10-Q Financial Statement
#000143462124000013 Filed on May 01, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
---|---|---|---|
Revenue | $210.1M | $167.8M | $134.4M |
YoY Change | 15.17% | -16.33% | -33.51% |
Cost Of Revenue | $8.411M | $8.545M | $8.126M |
YoY Change | -9.58% | -37.9% | -39.94% |
Gross Profit | $201.7M | $70.52M | $126.2M |
YoY Change | 16.5% | -11.8% | -33.05% |
Gross Profit Margin | 96.0% | 42.04% | 93.95% |
Selling, General & Admin | $175.5M | $134.0M | $108.6M |
YoY Change | 20.85% | -22.91% | -37.29% |
% of Gross Profit | 87.0% | 189.97% | 86.07% |
Research & Development | $10.37M | $11.86M | $11.10M |
YoY Change | -2.14% | -19.09% | -15.52% |
% of Gross Profit | 5.14% | 16.81% | 8.79% |
Depreciation & Amortization | $6.068M | $4.667M | $6.513M |
YoY Change | -8.97% | -2.67% | -26.01% |
% of Gross Profit | 3.01% | 6.62% | 5.16% |
Operating Expenses | $191.9M | $145.8M | $126.3M |
YoY Change | 18.13% | -22.62% | -35.31% |
Operating Profit | $9.782M | $7.179M | -$32.00K |
YoY Change | -8.23% | -155.18% | -99.52% |
Interest Expense | -$1.201M | -$6.638M | $10.69M |
YoY Change | -82.69% | -126.52% | -277.51% |
% of Operating Profit | -12.28% | -92.46% | |
Other Income/Expense, Net | $1.052M | $1.034M | $2.644M |
YoY Change | -44.01% | -43.62% | 29.8% |
Pretax Income | $9.438M | $1.575M | $13.12M |
YoY Change | 8326.79% | -88.63% | -215.67% |
Income Tax | $1.686M | $559.0K | $397.0K |
% Of Pretax Income | 17.86% | 35.49% | 3.03% |
Net Earnings | $7.752M | $1.016M | $12.72M |
YoY Change | -6840.87% | -92.45% | -222.25% |
Net Earnings / Revenue | 3.69% | 0.61% | 9.47% |
Basic Earnings Per Share | $0.58 | $0.08 | |
Diluted Earnings Per Share | $0.58 | $0.08 | $0.98 |
COMMON SHARES | |||
Basic Shares Outstanding | 13.22M shares | 13.04M shares | 13.00M shares |
Diluted Shares Outstanding | 13.41M shares | 13.28M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $66.77M | $230.7M | $112.1M |
YoY Change | -58.95% | 53.75% | -62.51% |
Cash & Equivalents | $66.77M | $230.7M | $112.1M |
Short-Term Investments | |||
Other Short-Term Assets | $31.46M | $31.62M | $29.48M |
YoY Change | 150.08% | 11.87% | -8.07% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $107.7M | $63.32M | $54.95M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $205.9M | $325.7M | $196.5M |
YoY Change | -22.12% | 24.31% | -52.54% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $101.2M | $48.30M | $50.48M |
YoY Change | -16.31% | -15.87% | -14.67% |
Goodwill | $381.5M | $381.5M | $381.5M |
YoY Change | -9.19% | -9.19% | -9.19% |
Intangibles | $47.67M | $49.13M | $50.62M |
YoY Change | -12.19% | -12.68% | -13.2% |
Long-Term Investments | $60.08M | $60.08M | $60.08M |
YoY Change | -65.3% | -65.59% | -65.59% |
Other Assets | $5.746M | $5.871M | $6.339M |
YoY Change | -7.05% | -7.09% | 3.9% |
Total Long-Term Assets | $596.3M | $601.0M | $606.3M |
YoY Change | -23.03% | -22.98% | -22.8% |
TOTAL ASSETS | |||
Total Short-Term Assets | $205.9M | $325.7M | $196.5M |
Total Long-Term Assets | $596.3M | $601.0M | $606.3M |
Total Assets | $802.2M | $926.7M | $802.8M |
YoY Change | -22.8% | -11.09% | -33.07% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.042M | $3.097M | $1.960M |
YoY Change | -4.16% | -30.76% | -3.45% |
Accrued Expenses | $95.17M | $69.72M | $70.54M |
YoY Change | 42.59% | -17.81% | -6.06% |
Deferred Revenue | $0.00 | ||
YoY Change | -100.0% | ||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $14.90M | $14.90M | $3.125M |
YoY Change | 495.8% | 495.96% | 25.0% |
Total Short-Term Liabilities | $113.1M | $87.71M | $75.63M |
YoY Change | 41.6% | -4.45% | -8.37% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $467.7M | $631.3M | $525.6M |
YoY Change | -25.19% | 0.96% | -35.39% |
Other Long-Term Liabilities | $72.45M | $278.0K | $267.0K |
YoY Change | -14.71% | -15.5% | -13.31% |
Total Long-Term Liabilities | $540.2M | $631.6M | $525.9M |
YoY Change | -23.94% | 0.95% | -35.38% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $113.1M | $87.71M | $75.63M |
Total Long-Term Liabilities | $540.2M | $631.6M | $525.9M |
Total Liabilities | $656.4M | $795.2M | $678.6M |
YoY Change | -17.69% | -1.99% | -31.55% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$828.9M | -$836.7M | -$837.7M |
YoY Change | 18.09% | 19.21% | 17.11% |
Common Stock | $1.241B | $1.234B | $1.228B |
YoY Change | 2.57% | 2.95% | 3.25% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $266.2M | $266.2M | $266.2M |
YoY Change | 0.0% | 0.0% | 0.0% |
Treasury Stock Shares | |||
Shareholders Equity | $145.8M | $131.5M | $124.1M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $802.2M | $926.7M | $802.8M |
YoY Change | -22.8% | -11.09% | -33.07% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $7.752M | $1.016M | $12.72M |
YoY Change | -6840.87% | -92.45% | -222.25% |
Depreciation, Depletion And Amortization | $6.068M | $4.667M | $6.513M |
YoY Change | -8.97% | -2.67% | -26.01% |
Cash From Operating Activities | -$4.943M | $5.708M | $20.88M |
YoY Change | -132.8% | -56.61% | 25.44% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $2.730M | $2.746M | $2.600M |
YoY Change | 13.7% | 11.99% | 5.14% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $2.000K | $50.00K | |
YoY Change | 614.29% | ||
Cash From Investing Activities | -$2.728M | -$2.746M | -$2.550M |
YoY Change | 13.62% | 11.99% | 3.41% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -156.3M | $115.7M | -81.86M |
YoY Change | 156221.0% | -172.54% | 9254.97% |
NET CHANGE | |||
Cash From Operating Activities | -4.943M | $5.708M | 20.88M |
Cash From Investing Activities | -2.728M | -$2.746M | -2.550M |
Cash From Financing Activities | -156.3M | $115.7M | -81.86M |
Net Change In Cash | -164.0M | $118.7M | -63.53M |
YoY Change | -1404.94% | -179.74% | -577.5% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$4.943M | $5.708M | $20.88M |
Capital Expenditures | $2.730M | $2.746M | $2.600M |
Free Cash Flow | -$7.673M | $2.962M | $18.28M |
YoY Change | -160.57% | -72.33% | 28.98% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
230979000 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
8545000 | usd |
CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
13760000 | usd |
CY2024Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
108176000 | usd |
CY2023Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
137111000 | usd |
CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
25796000 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
36683000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
11857000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14655000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4667000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4795000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1489000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2049000 | usd |
CY2024Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
23000 | usd |
CY2023Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
4454000 | usd |
CY2024Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-36000 | usd |
CY2023Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-12000 | usd |
CY2024Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
160589000 | usd |
CY2023Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
213519000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
7179000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13011000 | usd |
CY2024Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-6638000 | usd |
CY2023Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
25029000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1034000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1834000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1575000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
13852000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
559000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
395000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
1016000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1016000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
13457000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
13457000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
13100000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12846000 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
13276000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12935000 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.08 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.05 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.08 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.04 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
124132000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1016000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
1016000 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
7789000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
-1422000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
131515000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
207940000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
13457000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
13457000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
11274000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
-1693000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
1000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
13457000 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-368000 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-5027000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1489000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2049000 | usd |
CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
4667000 | usd |
CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
4795000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7789000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11274000 | usd |
CY2024Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
128000 | usd |
CY2023Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
360000 | usd |
CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-129000 | usd |
CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
963000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
612000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
1959000 | usd |
CY2024Q1 | us-gaap |
Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
|
0 | usd |
CY2023Q1 | us-gaap |
Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
|
2373000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
6000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | usd |
CY2024Q1 | tree |
Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
|
-1007000 | usd |
CY2023Q1 | tree |
Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
|
-877000 | usd |
CY2024Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
|
0 | usd |
CY2023Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
|
34308000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
8235000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
211000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2034000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1882000 | usd |
CY2024Q1 | tree |
Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
|
797000 | usd |
CY2023Q1 | tree |
Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
|
8559000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
|
86000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
|
42000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-155000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
424000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5708000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
13156000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
2746000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
2452000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2746000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2452000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
125000000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
0 | usd |
CY2024Q1 | us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
625000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
625000 | usd |
CY2024Q1 | tree |
Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
|
-1422000 | usd |
CY2023Q1 | tree |
Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
|
-1693000 | usd |
CY2024Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | usd |
CY2023Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
156294000 | usd |
CY2024Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
4085000 | usd |
CY2023Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
953000 | usd |
CY2024Q1 | us-gaap |
Payments Of Loan Costs
PaymentsOfLoanCosts
|
3125000 | usd |
CY2023Q1 | us-gaap |
Payments Of Loan Costs
PaymentsOfLoanCosts
|
0 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
115743000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-159565000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
118705000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-148861000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
112056000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
298969000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
230761000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
150108000 | usd |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is required to make certain estimates and assumptions during the preparation of the consolidated financial statements in accordance with GAAP. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. They also impact the reported amount of net earnings during any period. Actual results could differ from those estimates. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates underlying the accompanying consolidated financial statements include: the recoverability of long-lived assets, goodwill and intangible assets; the determination of income taxes payable and deferred income taxes, including related valuation allowances; fair value of assets acquired in a business combination; litigation accruals; contract assets; various other allowances, reserves and accruals; assumptions related to the determination of stock-based compensation; and the determination of right-of-use assets and lease liabilities. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the impact of the current economic conditions, including interest rates and inflation on the assumptions and estimates used when preparing its consolidated financial statements including, but not limited to, the allowance for doubtful accounts, valuation allowances, contract asset, and the recoverability of long-lived assets, goodwill and intangible assets. These assumptions and estimates may change as new events occur and additional information is obtained. If economic conditions worsen, such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity.</span></div> | |
CY2024Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Risks and Concentrations</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LendingTree's business is subject to certain risks and concentrations including dependence on third-party technology providers, exposure to risks associated with online commerce security and fraud.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk at March 31, 2024, consist primarily of cash and cash equivalents and accounts receivable, as disclosed in the consolidated balance sheet. Cash and cash equivalents are in excess of Federal Deposit Insurance Corporation insurance limits, but are maintained with quality financial institutions of high credit. The Company requires certain Network Partners to maintain security deposits with the Company, which in the event of non-payment, would be applied against any accounts receivable outstanding.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the mortgage lending industry, interest rate fluctuations may negatively impact future revenue from the Company's marketplace.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lenders and lead purchasers participating on the Company's marketplace can offer their products directly to consumers through brokers, mass marketing campaigns or through other traditional methods of credit distribution. These lenders and lead purchasers can also offer their products online, either directly to prospective borrowers, through one or more online competitors, or both. If a significant number of potential consumers are able to obtain loans and other products from Network Partners without utilizing the Company's services, the Company's ability to generate revenue may be limited. Because the Company does not have exclusive relationships with the Network Partners whose loans and other financial products are offered on its online marketplace, consumers may obtain offers from these Network Partners without using its service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than a support services office in India, the Company's operations are geographically limited to and dependent upon the economic condition of the United States.</span></div> | |
CY2024Q1 | us-gaap |
Revenues
Revenues
|
167768000 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
200508000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
15100000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
13700000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
0 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
800000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
|
300000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
|
200000 | usd |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
230745000 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
112051000 | usd |
CY2024Q1 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
16000 | usd |
CY2023Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
5000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
230761000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
112056000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
2222000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
2317000 | usd |
CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-129000 | usd |
CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
963000 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
67000 | usd |
CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
963000 | usd |
CY2024Q1 | tree |
Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
|
0 | usd |
CY2023Q1 | tree |
Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
|
371000 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
2026000 | usd |
CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
2688000 | usd |
CY2024Q1 | us-gaap |
Goodwill Gross
GoodwillGross
|
903227000 | usd |
CY2023Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
903227000 | usd |
CY2024Q1 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
521688000 | usd |
CY2023Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
521688000 | usd |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
381539000 | usd |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
381539000 | usd |
CY2024Q1 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
10142000 | usd |
CY2023Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
10142000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
38990000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
40478000 | usd |
CY2024Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
49132000 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
50620000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
76100000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
37110000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
38990000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
77400000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
36922000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
40478000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
4401000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
5830000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
5504000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
5198000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
4685000 | usd |
CY2024Q1 | tree |
Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
|
13372000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
38990000 | usd |
CY2023Q3 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
|
113100000 | usd |
CY2024Q1 | us-gaap |
Accrued Advertising Current
AccruedAdvertisingCurrent
|
37334000 | usd |
CY2023Q4 | us-gaap |
Accrued Advertising Current
AccruedAdvertisingCurrent
|
27859000 | usd |
CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
8072000 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
15091000 | usd |
CY2024Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
816000 | usd |
CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1101000 | usd |
CY2024Q1 | tree |
Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
|
7113000 | usd |
CY2023Q4 | tree |
Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
|
7732000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
6637000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
7387000 | usd |
CY2024Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
9745000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
11374000 | usd |
CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
69717000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
70544000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
13100000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12846000 | shares |
CY2024Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
61000 | shares |
CY2023Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
54000 | shares |
CY2024Q1 | tree |
Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
|
115000 | shares |
CY2023Q1 | tree |
Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
|
35000 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
13276000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12935000 | shares |
CY2023Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
0 | shares |
CY2024Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
0 | shares |
CY2024Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
96700000 | usd |
CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
7789000 | usd |
CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
11274000 | usd |
CY2024Q1 | us-gaap |
Share Price
SharePrice
|
42.34 | |
CY2024Q1 | us-gaap |
Share Price
SharePrice
|
42.34 | |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
559000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
395000 | usd |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.355 | |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.029 | |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2023Q4 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
200000 | usd |
CY2024Q1 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
200000 | usd |
CY2024Q1 | us-gaap |
Litigation Reserve
LitigationReserve
|
700000 | usd |
CY2023Q4 | us-gaap |
Litigation Reserve
LitigationReserve
|
600000 | usd |
CY2024Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
3 | segment |
CY2024Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
3 | segment |
CY2024Q1 | us-gaap |
Revenues
Revenues
|
167768000 | usd |
CY2024Q1 | us-gaap |
Marketing Expense
MarketingExpense
|
97246000 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
70522000 | usd |
CY2024Q1 | us-gaap |
Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
|
8545000 | usd |
CY2024Q1 | us-gaap |
Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
|
10930000 | usd |
CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
25796000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
11857000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4667000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1489000 | usd |
CY2024Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
23000 | usd |
CY2024Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-36000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
7179000 | usd |
CY2024Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-6638000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1034000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1575000 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
200508000 | usd |
CY2023Q1 | us-gaap |
Marketing Expense
MarketingExpense
|
120551000 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
79957000 | usd |
CY2023Q1 | us-gaap |
Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
|
13760000 | usd |
CY2023Q1 | us-gaap |
Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
|
16560000 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
36683000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14655000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4795000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2049000 | usd |
CY2023Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
4454000 | usd |
CY2023Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-12000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13011000 | usd |
CY2023Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
25029000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1834000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
13852000 | usd |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false |